Analysis of Residual Ethylene Oxide in Medical Devices - No. 362

Importance of Topic

Residual ethylene oxide monitoring in medical devices is critical due to its toxicity and regulatory limits. It ensures patient safety, minimizes health risks, and supports compliance with sterilization standards.

Study Objectives and Overview

This application study demonstrates a gas chromatography method using a flame ionization detector and a polar wax column to quantify trace levels of ethylene oxide (EO), ethylene chlorohydrin (ECH), and ethylene glycol (EG) in polymeric device matrices.

Methodology and Instrumentation

A Shimadzu Nexis GC-2030 coupled with an AOC-20i Plus autosampler was employed. Samples were introduced via split injection (1:3 ratio) at 250 °C. The SH-PolarWax column (30 m × 0.53 mm I.D., 1.00 µm film) was temperature-programmed from 60 °C (3 min) to 200 °C at 20 °C/min, completing in 20 min. Nitrogen served as the carrier and makeup gas; hydrogen and air supported the FID flame. A 0.5 µL injection volume was delivered with an elastic titanium-plunger syringe for stable sample introduction.

Instrumentation

• Shimadzu Nexis GC-2030 with AOC-20i Plus autosampler
• FID-2030 Flame Ionization Detector
• SH-PolarWax column (30 m × 0.53 mm I.D., 1.00 µm film)
• Elastic titanium-plunger syringe (0.5 µL volume)

Main Results and Discussion

Chromatographic separation achieved baseline resolution of EO, ECH, and EG within a 20-minute cycle. The method exhibited consistent retention times and reproducible peak areas, confirming its robustness for trace-level analysis of sterilization byproducts.

Benefits and Practical Applications

• High sensitivity and selectivity for residual EO detection
• Rapid analysis time compatible with routine QA/QC workflows
• Stable injection performance ensuring reproducibility
• Alignment with regulatory requirements for medical device safety

Future Trends and Applications

Emerging directions include coupling gas chromatography with mass spectrometry for enhanced compound identification, miniaturized sampling and automated headspace techniques for higher throughput, and adopting green analytical approaches to reduce solvent and energy consumption.

Conclusion

The described GC-FID protocol using a polar wax column provides a reliable, rapid, and sensitive solution for quantifying residual ethylene oxide and related compounds in medical devices, enhancing patient safety and regulatory adherence.

References

• Application News 01-00139 (JP, ENG), Shimadzu Corporation, First Edition Sep. 2022